217 related articles for article (PubMed ID: 19238308)
1. Use of anti-depressants and the risk of fracture of the hip or femur.
van den Brand MW; Pouwels S; Samson MM; van Staa TP; Thio B; Cooper C; Leufkens HG; Egberts AC; Verhaar HJ; de Vries F
Osteoporos Int; 2009 Oct; 20(10):1705-13. PubMed ID: 19238308
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.
Arbouw ME; Movig KL; van Staa TP; Egberts AC; Souverein PC; de Vries F
Osteoporos Int; 2011 Jul; 22(7):2197-204. PubMed ID: 20967420
[TBL] [Abstract][Full Text] [Related]
3. Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
de Vries F; Pouwels S; Lammers JW; Leufkens HG; Bracke M; Cooper C; van Staa TP
J Intern Med; 2007 Feb; 261(2):170-7. PubMed ID: 17241182
[TBL] [Abstract][Full Text] [Related]
4. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
Pouwels S; van Staa TP; Egberts AC; Leufkens HG; Cooper C; de Vries F
Osteoporos Int; 2009 Sep; 20(9):1499-506. PubMed ID: 19156348
[TBL] [Abstract][Full Text] [Related]
6. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures.
Verdel BM; Souverein PC; Egberts TC; van Staa TP; Leufkens HG; de Vries F
Bone; 2010 Sep; 47(3):604-9. PubMed ID: 20601295
[TBL] [Abstract][Full Text] [Related]
7. Elderly patients, use of antidepressants, and hip fracture.
Gambassi G; Lapane KL; Sgadari A; Bernabei R
Lancet; 1998 Aug; 352(9125):400; author reply 401-2. PubMed ID: 9717946
[No Abstract] [Full Text] [Related]
8. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
Pouwels S; Lalmohamed A; Souverein P; Cooper C; Veldt BJ; Leufkens HG; de Boer A; van Staa T; de Vries F
Osteoporos Int; 2011 Mar; 22(3):903-10. PubMed ID: 20585937
[TBL] [Abstract][Full Text] [Related]
9. The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.
Shen SP; Liu Y; Qiu H; Tsai KY; Wu HC; Liang WM; Shu M; Chou FH
PLoS One; 2019; 14(9):e0221948. PubMed ID: 31487309
[TBL] [Abstract][Full Text] [Related]
10. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.
Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
Age Ageing; 2013 Jul; 42(4):514-20. PubMed ID: 23438446
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective serotonin reuptake inhibitors and other antidepressant drugs on the risk of hip fracture: a case-control study in an elderly Mediterranean population.
Gorgas MQ; Torres F; Vives R; Lopez-Rico I; Capella D; Pontes C
Eur J Hosp Pharm; 2021 Jan; 28(1):28-32. PubMed ID: 33355280
[TBL] [Abstract][Full Text] [Related]
13. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
de Vries F; Pouwels S; Bracke M; Leufkens HG; Cooper C; Lammers JW; van Staa TP
Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):612-9. PubMed ID: 16998945
[TBL] [Abstract][Full Text] [Related]
14. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
Hubbard R; Farrington P; Smith C; Smeeth L; Tattersfield A
Am J Epidemiol; 2003 Jul; 158(1):77-84. PubMed ID: 12835289
[TBL] [Abstract][Full Text] [Related]
15. Use of alpha-blockers and the risk of hip/femur fractures.
Souverein PC; Van Staa TP; Egberts AC; De la Rosette JJ; Cooper C; Leufkens HG
J Intern Med; 2003 Dec; 254(6):548-54. PubMed ID: 14641795
[TBL] [Abstract][Full Text] [Related]
16. Elderly patients, use of antidepressants, and hip fracture.
Verlhac B; Wolmark Y; Forette B
Lancet; 1998 Aug; 352(9125):401; author reply 401-2. PubMed ID: 9717948
[No Abstract] [Full Text] [Related]
17. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
18. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
Vestergaard P; Prieto-Alhambra D; Javaid MK; Cooper C
Osteoporos Int; 2013 Feb; 24(2):671-80. PubMed ID: 22669469
[TBL] [Abstract][Full Text] [Related]
19. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
[TBL] [Abstract][Full Text] [Related]
20. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
